MedPath

Maxigesic Metabolism Study: To describe the metabolism of paracetamol when combined with ibuprofen in healthy adult volunteers.

Phase 1
Completed
Conditions
Pharmacokinetics of Maxigesic in Healthy Volunteers.
Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
Registration Number
ACTRN12612000871842
Lead Sponsor
AFT Pharmacetuicals Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
12
Inclusion Criteria

1) Provide written informed consent
2) Have Body Mass Index between 18.5 and 30.0 kg/m2
3) Healthy volunteers as determined by medical history, physical examination, ECG, vital signs and laboratory tests

Exclusion Criteria

1) Women who are pregnant or nursing
2) Women who are unwilling to take adequate contraceptive precaustions or who are unwilling to undergo urine pregnancy testing
3) History of alcohol or drug abuse or dependency
4) Have a history of allergy or hypersensitivity to ibuprofen, aspirin, any other NSAID or paracetamol
5) Have haemopoetic, renal or hepatic disease, immunosupression. Have a history of gastric ulceration, indigestion, stomach pain, GI bleeding or bleeding disorders. Are currently suffering from dehydration from diarrhoea and/or vomiting. Have a history of severe asthma. Have a history of severe hypertension, ventricular tachycardia or other cardiac disease. Have insulin dependent diabetes mellitus.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath